Question 1

Does ExodusPoint Capital Management own AMLX stock?

Accepted Answer

No. ExodusPoint Capital Management exited its AMLX (Amylyx Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 59,491 shares worth $211,000.

Question 2

How many shares of AMLX does ExodusPoint Capital Management own?

Accepted Answer

None since Q2 2025, when ExodusPoint Capital Management exited the position. Its Q1 2025 13F listed 59,491 shares worth $211,000.

Question 3

What is ExodusPoint Capital Management's AMLX position worth?

Accepted Answer

ExodusPoint Capital Management's AMLX position was worth $211,000 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is ExodusPoint Capital Management buying or selling AMLX?

Accepted Answer

In Q2 2025, ExodusPoint Capital Management exited its entire AMLX position.

Question 5

When did ExodusPoint Capital Management first buy AMLX?

Accepted Answer

ExodusPoint Capital Management first reported AMLX in its Q2 2022 13F and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$6.41	0
2025-Q1	Decreased	59,491	-44.0%	$211,000	0.0%	$3.54	0
2024-Q4	New	106,237	—	$402,000	0.0%	$3.78	33